首页> 美国卫生研究院文献>Oncotarget >Risk factors associated with fatality of severe fever with thrombocytopenia syndrome: a meta-analysis
【2h】

Risk factors associated with fatality of severe fever with thrombocytopenia syndrome: a meta-analysis

机译:与血小板减少症综合征严重发热死亡相关的危险因素:一项荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Severe fever with thrombocytopenia syndrome is an emerging life-threatening infectious disease identified in 2009. Given high case-fatality rate among patients with severe fever with thrombocytopenia syndrome, identification of the risk factors at acute phase associated with fatality is crucial for treatment. Therefore, we aimed to meta-analytically evaluate risk factors of fatal clinical outcome of severe fever with thrombocytopenia syndrome. 238 fatal cases and 873 non-fatal cases from 12 studies were included in this meta-analysis. Elder age and high viral load were significantly associated with fatal clinical outcome. Further, severe fever with thrombocytopenia syndrome patients with fatal clinical outcome had significantly reduced level of albumin and platelet count, higher level of serum alanine aminotransferase, aspirate aminotransferase, lactic acid dehydrogenase and creatinine phosphokinase, and prolonged activated partial thromboplastin time, comparing with mild patients. These disturbed parameters function as predictors to warn fatal clinical outcome of the disease. Moreover, ribavirin has a minimal impact to alleviate disease progression of severe fever with thrombocytopenia syndrome. In conclusion, our finding demonstrates a panel of factors associated with fatality of SFTS disease, which have important implications during clinical practice.
机译:血小板减少综合征的重度发烧是一种在2009年发现的威胁生命的新兴传染病。鉴于患有血小板减少症的重度发热的患者中高病死率,确定与死亡相关的急性期危险因素对于治疗至关重要。因此,我们旨在荟萃分析评估严重发热伴血小板减少综合征的致命临床结果的危险因素。这项荟萃分析包括来自12个研究的238例致命病例和873例非致命病例。高龄和高病毒载量与致命的临床结果显着相关。此外,与轻度患者相比,具有致命临床结局的重度发热伴血小板减少综合征的患者白蛋白和血小板计数水平明显降低,血清丙氨酸氨基转移酶,吸出性氨基转移酶,乳酸脱氢酶和肌酐磷酸激酶水平升高,活化的部分凝血活酶时间延长。这些干扰的参数起着警告疾病的致命临床后果的预测作用。此外,利巴韦林对减轻严重血小板减少症伴发烧的疾病进展的影响很小。总之,我们的发现证明了一系列与SFTS病死相关的因素,这些因素在临床实践中具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号